Literature DB >> 21640348

Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: a randomized, controlled trial.

Rosa Solá1, Montserrat Fitó, Ramón Estruch, Jordi Salas-Salvadó, Dolores Corella, Rafael de La Torre, Miguel Angel Muñoz, María del Carmen López-Sabater, Miguel-Angel Martínez-González, Fernando Arós, Valentina Ruiz-Gutierrez, Miquel Fiol, Elena Casals, Julia Wärnberg, Pilar Buil-Cosiales, Emilio Ros, Valentini Konstantinidou, José Lapetra, Lluis Serra-Majem, María-Isabel Covas.   

Abstract

OBJECTIVES: Apolipoprotein (Apo)B, ApoA-I, and their ratio could predict coronary heart disease (CHD) risk more accurately than conventional lipid measurements. Our aim was to assess the effect of a traditional Mediterranean diet (TMD) on apolipoproteins.
METHODS: High-cardiovascular risk subjects (n=551, 308 women and 243 men), aged 55-80 years, were recruited into a large, multicenter, randomized, controlled, parallel-group, clinical trial (The PREDIMED Study) aimed at testing the efficacy of TMD on primary cardiovascular disease prevention. Participants assigned to a low-fat diet (control) (n=177), or TMDs (TMD+virgin olive oil (VOO), n=181 or TMD+nuts, n=193) received nutritional education and either free VOO (ad libitum) or nuts (dose: 30 g/day). A 3-month evaluation was performed.
RESULTS: Both TMDs promoted beneficial changes on classical cardiovascular risk factors. ApoA-I increased, and ApoB and ApoB/ApoA-I ratio decreased after TMD+VOO, the changes promoting a lower cardiometabolic risk. Changes in TMD+VOO versus low-fat diet were -2.9 mg/dL (95% CI, -5.6 to -0.08), 3.3mg/dL (95% CI, 0.84 to 5.8), and -0.03 mg/dL (-0.05 to -0.01) for ApoB, ApoA-I, and ApoB/ApoA-I ratio, respectively.
CONCLUSIONS: Individuals at high-cardiovascular risk who improved their diet toward a TMD pattern rich in virgin olive oil, reduced their Apo B and ApoB/ApoA-I ratio and improved ApoA-I concentrations.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640348     DOI: 10.1016/j.atherosclerosis.2011.04.026

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  36 in total

1.  Intervention Trials with the Mediterranean Diet in Cardiovascular Prevention: Understanding Potential Mechanisms through Metabolomic Profiling.

Authors:  Miguel Á Martínez-González; Miguel Ruiz-Canela; Adela Hruby; Liming Liang; Antonia Trichopoulou; Frank B Hu
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

2.  Sex-specific association of the SPTY2D1 rs7934205 polymorphism and serum lipid levels.

Authors:  Tao Guo; Rui-Xing Yin; Xia Chen; Yuan Bin; Rong-Jun Nie; Hui Li
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Can changes in the plasma lipidome help explain the cardiovascular benefits of the Mediterranean diet?

Authors:  Archna Bajaj; Daniel J Rader
Journal:  Am J Clin Nutr       Date:  2017-09-13       Impact factor: 7.045

4.  Association between the GPAM rs1129555 SNP and serum lipid profiles in the Maonan and Han populations.

Authors:  Shuo Yang; Rui-Xing Yin; Liu Miao; Qing-Hui Zhang; Yong-Gang Zhou; Jie Wu
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

5.  Association of the SPT2 chromatin protein domain containing 1 gene rs17579600 polymorphism and serum lipid traits.

Authors:  Tao Guo; Rui-Xing Yin; Yuan Bin; Rong-Jun Nie; Xia Chen; Shang-Ling Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Adherence to a priori dietary indexes and baseline prevalence of cardiovascular risk factors in the PREDIMED-Plus randomised trial.

Authors:  Ismael Alvarez-Alvarez; Estefanía Toledo; Oscar Lecea; Jordi Salas-Salvadó; Dolores Corella; Pilar Buil-Cosiales; María Dolores Zomeño; Jesús Vioque; J Alfredo Martinez; Jadwiga Konieczna; Francisco J Barón-López; José López-Miranda; Ramon Estruch; Aurora Bueno-Cavanillas; Ángel M Alonso-Gómez; Josep A Tur; Francisco J Tinahones; Lluís Serra-Majem; Vicente Martín; Manuel Ortega-Calvo; Clotilde Vázquez; Xavier Pintó; Josep Vidal; Lidia Daimiel; Miguel Delgado-Rodríguez; Pilar Matía; José I González; Andrés Díaz-López; Indira Paz-Graniel; Miguel A Muñoz; Montse Fito; Salvador Pertusa-Martinez; Itziar Abete; Antonio García-Ríos; Emilio Ros; Miguel Ruiz-Canela; Miguel Á Martínez-González
Journal:  Eur J Nutr       Date:  2019-05-09       Impact factor: 5.614

7.  A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.

Authors:  Michele L Mietus-Snyder; Mark K Shigenaga; Jung H Suh; Swapna V Shenvi; Ashutosh Lal; Tara McHugh; Don Olson; Joshua Lilienstein; Ronald M Krauss; Ginny Gildengoren; Joyce C McCann; Bruce N Ames
Journal:  FASEB J       Date:  2012-05-01       Impact factor: 5.191

8.  Association of the Trp316Ser variant (rs1801690) near the apolipoprotein H (β2-glycoprotein-I) gene and serum lipid levels.

Authors:  Tao Guo; Rui-Xing Yin; Hui Li; Yi-Ming Wang; Jin-Zhen Wu; De-Zhai Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Suppressor of cytokine signaling 3 A+930-->G (rs4969168) polymorphism is associated with apolipoprotein A1 and low-density lipoprotein cholesterol.

Authors:  Tao Guo; Rui-Xing Yin; Rong-Jun Nie; Xia Chen; Yuan Bin; Wei-Xiong Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer.

Authors:  Sara Fernández-Castillejo; Laura Rubió; Álvaro Hernáez; Úrsula Catalán; Anna Pedret; Rosa-M Valls; Juana I Mosele; Maria-Isabel Covas; Alan T Remaley; Olga Castañer; Maria-José Motilva; Rosa Solá
Journal:  Mol Nutr Food Res       Date:  2017-10-26       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.